| ZETACOLEST PLUS tablets, for oral use, contains:
Each film coated tablet contains:
First layer:
• The active ingredient is bempedoic acid 180 mg.
Second layer:
• The active ingredient is ezetimibe.
Indications and usage:
ZETACOLEST PLUS, a combination of bempedoic acid and ezetimibe, is indicated:
As an adjunct to diet, alone or in combination with other low-density lipoprotein
cholesterol (LDL-C) lowering therapies, to reduce LDL-C in adults with primary
hyperlipidemia, including heterozygous familial hypercholesterolemia (HeFH).
The bempedoic acid component of ZETACOLEST PLUS is indicated:
To reduce the risk of myocardial infarction and coronary revascularization in adults who
are unable to take recommended statin therapy (including those not taking a statin) with:
o established cardiovascular disease (CVD), or o a high risk for a CVD event but without established CVD
How supplied / storage and handling
Pack: Carton box containing (Al\Al) strip each of 10 film coated tablet + leaflet Insert.
For number of strips see outer pack
|
